| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Journal of the American Society of Nephrology, Vol 5, 1081-1090, Copyright © 1994 by American Society of Nephrology
REGULAR ARTICLES |
A Kramer-Guth, M Nauck, H Pavenstadt, M Koniger, H Wieland, P Schollmeyer and C Wanner
Department of Medicine, University of Freiburg, Germany.
Hyperlipidemia of nephrotic origin could potentially cause glomerular injury as well as increase the risk of atherosclerosis. The precise interaction of human lipoproteins abnormal in lipid and protein composition, with lipoprotein receptors has not been clearly defined. This study examines receptor-mediated uptake and intracellular cholesterol metabolism of apolipoprotein (apo)B,E containing intermediate-density lipoprotein (IDL) and apoB-100 containing low- density lipoprotein (LDL), isolated from patients with the nephrotic syndrome (N = 6), in human glomerular mesangial and HepG2 cells. In the patients, serum IDL and LDL cholesterol levels were significantly increased as compared with those of healthy subjects. The IDL of nephrotic patients contained 80% more cholesterol than the IDL of healthy controls. No differences in lipid/protein composition were found in the LDL density range. Therefore, nephrotic and control LDL showed identical affinities for receptor-mediated uptake. In contrast, the IDL of nephrotic patients was taken up by mesangial cells and HepG2 with higher affinity than the LDL. Intracellular sterol synthesis was suppressed more effectively and cholesterol esterification rate was enhanced 2.2-fold by nephrotic IDL as compared with control IDL. These data indicate that hypercholesterolemia of nephrotic origin cannot be explained by reduced ligand binding for LDL. ApoE-containing IDL of patients with the nephrotic syndrome were avidly taken up by glomerular mesangial cells and could therefore play the predominant role in the development of glomerulosclerosis and atherosclerosis associated with this disorder.
This article has been cited by other articles:
![]() |
J. A. JOLES, U. KUNTER, U. JANSSEN, W. KRIZ, T. J. RABELINK, H. A. KOOMANS, and J. FLOEGE Early Mechanisms of Renal Injury in Hypercholesterolemic or Hypertriglyceridemic Rats J. Am. Soc. Nephrol., April 1, 2000; 11(4): 669 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. MIYATA, S. SUGIYAMA, M. NANGAKU, D. SUZUKI, K.-I. URAGAMI, R. INAGI, H. SAKAI, and K. KUROKAWA Apolipoprotein E2/E5 Variants in Lipoprotein Glomerulopathy Recurred in Transplanted Kidney J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1590 - 1595. [Abstract] [Full Text] |
||||
![]() |
T. QUASCHNING, M. SCHÖMIG, M. KELLER, J. THIERY, M. NAUCK, P. SCHOLLMEYER, C. WANNER, and A. KRÄMER-GUTH Non-Insulin-Dependent Diabetes Mellitus and Hypertriglyceridemia Impair Lipoprotein Metabolism in Chronic Hemodialysis Patients J. Am. Soc. Nephrol., February 1, 1999; 10(2): 332 - 341. [Abstract] [Full Text] |
||||
![]() |
A. Kramer-Guth, G. L. Busch, N. K. Kaba, S. Schwedler, C. Wanner, and F. Lang Effect of osmolarity on LDL binding and internalization in hepatocytes Am J Physiol Cell Physiol, October 1, 1997; 273(4): C1409 - C1415. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673